Development and validation of a clinical risk prediction model for chronic sinusitis with nasal polyps: a retrospective analysis. [PDF]
Li D +6 more
europepmc +1 more source
Experience of People With Chronic Sinusitis During COVID-19 Lockdown in Saudi Arabia: Insights and Lessons. [PDF]
Aldrees T +3 more
europepmc +1 more source
HISTOPATHOLOGICAL STUDIES ON THE CHRONIC PARANASAL SINUSITIS
Kosuke Imura
openalex +2 more sources
Study of Anatomical Variations on CT in Chronic Sinusitis
R. Tiwari, R. Goyal
semanticscholar +1 more source
Objective We evaluate tofacitinib efficacy and safety in patients with juvenile idiopathic arthritis (JIA) stratified by concomitant methotrexate and prior biologic disease‐modifying antirheumatic drug (bDMARD) treatment. Methods In this two part, double‐blind, randomized withdrawal Phase 3 trial (NCT02592434), patients (2–<18 years) with JIA received ...
Nicolino Ruperto +25 more
wiley +1 more source
Mechanistic studies on the role of CHI3L1 in eosinophilic inflammation in chronic sinusitis. [PDF]
Guo L +6 more
europepmc +1 more source
YES-associated protein-regulated Smad7 worsen epithelial barrier injury of chronic sinusitis with nasal polyps. [PDF]
Jiang X +6 more
europepmc +1 more source
STATISTICAL INVESTIGATION ON THE INCIDENCE OF CHRONIC SINUSITIS IN CHILDREN
Eiichi Hirabayashi
openalex +2 more sources
The Future of ORLHNS and Associated Specialties Series: The future of rhinology, anterior skull base and facial plastic surgery [PDF]
Lund, VJ, Rowe-Jones, JM
core +1 more source
Key Points 1 versus 0 PDs within 90 days of initial ESS was associated with 11% decreased risk of revision ESS. 2 versus 1 PD or a first PD 8–30 versus 1–7 days after initial ESS did not affect risk of revision ESS. 3+ versus 1 PD or a first PD 31–90 versus 1–7 days after initial ESS was associated with increased risk of revision ESS.
Max J. Hyman +3 more
wiley +1 more source

